Article info

PDF
Extended report
Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study

Authors

  1. Correspondence to Dr Mark C Genovese, Division of Immunology and Rheumatology, Stanford University, 1000 Welch RD #203, Palo Alto, CA 94304, USA; genovese{at}stanford.edu
View Full Text

Citation

Genovese MC, Durez P, Richards HB, et al
Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study

Publication history

  • Received February 28, 2012
  • Accepted May 20, 2012
  • First published June 23, 2012.
Online issue publication 
May 10, 2013

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.